myAirvo 2

Humidified high flow therapy system

Deliver humidified high flows from 2-60 L/min to chronic respiratory patients at home or in long-term care facilities.

Request information

Buy Now

Video guides and instructions for use

myAirvo 2 system components

Learn how myAirvo™ 2 can help patients manage chronic respiratory conditions

Humidified high flow therapy has been shown to ease symptoms such as frequent coughs and breathlessness as well as reduce escalation of care in patients with conditions such as COPD.^1-4 The myAirvo 2 is an innovative humidified high flow system that delivers the therapy through an Optiflow™ nasal cannula and a trio of advanced technologies.

Discover the myAirvo 2 technology

Advanced humidity algorithm

The myAirvo 2 algorithm’s intelligent controls deliver Optimal Humidity to patients at 37, 34 or 31 °C.

myAirvo 2 air pathway

A uniquely designed air pathway thoroughly conditions the mix of air and oxygen to accurately deliver the patient’s set flow rate.

AirSpiral™ Tube

The two-spiral design produces up to 93% less condensate*, maximizing humidity levels of the breathing gas.

*When compared with Airvo tube 900PT501 in internal F&P testing

Choose between two myAirvo 2 setups

Set up with the Reusable Chamber

Engineered to last up to two years and dishwasher safe.

A. myAirvo 2 device
B. Reusable Chamber
C. Compact Stand
D. AirSpiral Tube
E. Optiflow interfaces for adult and peadiatric applications, including nasal cannula, tracheostomy and mask adapter options

Set up with the Auto-fill Chamber

Designed for use with the Water Bag for longer therapy sessions.

A. myAirvo 2 device
B. Auto-fill Chamber
C. Water Bag
D. Compact Stand
E. AirSpiral Tube
F. Optiflow interfaces for adult and peadiatric applications, including nasal cannula, tracheostomy and mask adapter options

View more myAirvo support resources

Looking for more information?

myAirvo 2 and Airvo 2 are part of a humidified high flow system designed to treat patients in hospitals, long-term care facilities and in the home.

If you are wanting to learn more about these products and their accessories, select from one of the three options below to request information tailor-made to meet your needs.

Storgaard LH, et al. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195-1205. View abstract
Storgaard LH, et al. COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study. COPD. 2020;17(2). View abstract
Rea H, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104:525-533. View abstract
Nagata K, et al. Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD Patients: A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 2022, 206 (11). View abstract

View references

F&P, myAirvo, Airvo, AirSpiral and Optiflow are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see www.fphcare.com/ip